Usefulness of semiquantitative PCR‐Invader assay for selecting candidates for daclatasvir plus asunaprevir combination therapy among patients with hepatitis C virus genotype 1b
Koichi Honda(Yamagata University), Kazunari Murakami(Oita University), Junya Oribe(Oita University), Masataka Seike(Oita University), Masao Iwao, Junko Nishimura(Honda (Japan)), Toyokichi Muro(Nagasaki Medical Center), Kaoru Ômori(Daiyukai General Hospital), Mizuki Endo(Oita University), Mie Arakawa(Oita University), Tetsu Mori(Oita University), Tsutomu Yamashita(Nagasaki Medical Center), Yukou Takahashi(Oita University Hospital), Masanori Tokoro(Oita University)
Cited by 2
Related Papers
Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment
|Digestive Endoscopy|2013|469
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis
|Hepatology|2006|365
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Guidelines for Gastroenterological Endoscopy in Patients Undergoing Antithrombotic Treatment: 2017 Appendix on Anticoagulants Including Direct Oral Anticoagulants
|Digestive Endoscopy|2018|261
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
|Journal of Gastroenterology|2018|242